DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom’s World Diabetes Day ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, quarterly performance, and ...

Although DexCom stock has trailed the broader market over the past year, analysts remain bullish about its prospects.

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

Carrot’s Sprints members will have access to sleep, stress, activity and glucose data from Oura and Dexcom, along with ...

Now, it’s worth noting Stock Advisor’s total average return is 1,055% — a market-crushing outperformance compared to 194 % ...

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...